Results 131 to 140 of about 105,927 (341)
Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children [PDF]
, 2017 AW and JK are supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of AberdeenPeer reviewedPublisher ...
King, Jill +4 more
core +1 more source
Clinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa +2 more
wiley +1 more source
Aspergillus spondylodiscitis in a patient with liver cirrhosis and diabetes mellitus
Zdravniški Vestnik, 2014 Aspergillus osteomyelitis is a rare manifestation of invasive aspergillosis which accounts for 1.8% to 5.6% of all invasive aspergillosis forms. As other forms of invasive aspergillosis, it predominantly occurs in immunosupressed patients with well ...
Tereza Rojko +4 more
doaj
Mycoses, Volume 69, Issue 2, February 2026.ABSTRACT Introduction Relapses occur in up to 40% of patients after prolonged courses of antifungal treatment for chronic pulmonary aspergillosis (CPA). The factors predisposing to relapse remain poorly defined. Methods We conducted a retrospective study of adults treated for ≥ 6 months with oral azoles for CPA.
Annabel Choyce +6 more
wiley +1 more source
Diagnostic and Interventional Imaging, 2015 Aspergillosis is a mycotic disease usually caused by Aspergillus fumigatus, a saprophytic and ubiquitous airborne fungus. Aspergillus-related lung diseases are traditionally classified into four different forms, whose occurrence depends on the immunologic status of the host and the existence of an underlying lung disease.
Chabi, M.L. +5 more
openaire +2 more sources
Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside
Antimicrobial Agents and Chemotherapy, 2019 Echinocandins (caspofungin, micafungin, anidulafungin), targeting β-1,3-glucan synthesis of the cell wall, represent one of the three currently available antifungal drug classes for the treatment of invasive fungal infections.
M. Aruanno, E. Glampedakis, F. Lamoth
semanticscholar +1 more source
Ecology and Evolution, Volume 16, Issue 1, January 2026.Birds, insects and air each host distinct fungal spore communities in a Japanese temperate forest; birds and insects act as selective vectors, while air provides maximal diversity. Our study highlights the importance of analysing multiple taxa to understand ecosystem‐level fungal spore dispersal and interactions.
Rohit Bangay +2 more
wiley +1 more source
Determining whether estimated spore release rates for Aspergillus fumigatus are compatible with their measured growth rates in composting systems [PDF]
, 2008 The composting process like other waste management activities has the potential to generate large concentrations of bioaerosols which can be widely dispersed into the surrounding environment.
Fletcher, L.A. +2 more
core
Ecosphere, Volume 17, Issue 1, January 2026.Abstract Scleractinian coral evolved under nitrogen (N)‐limited conditions. The increase in N flux from anthropogenic activities to these otherwise N‐depleted environments is threatening coral health and coral reef ecosystem function. We tested the effect of elevated ammonium (NH4+) loading on Acropora metabolism responses (respiration, gross primary ...
Molly A. Fisher +3 more
wiley +1 more source